MarketCapExport financials
TEGNA (TGNA)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
TEGNA Financial Ratios 2025-2006 | TGNA
Brief overview of TEGNA 's valuation multiples
The comparison uses the five latest available annual observations between 2021 and 2025.
The current valuation set is P/E 15.28x (median 6.22x), EV/EBITDA 10.61x (median 9.92x), P/S 1.24x (median 1.2x). On average, multiples differ from their five-year medians by only +7%. Valuation is near its familiar historical range.
At the current P/E, inverse earnings yield is 6.5%, a useful bridge between price and business earnings.
Current measures of operating quality are ROE 7%, ROA 3.2%, ROCE 6.9%. Profitability remains low. Market valuation has limited fundamental support until resource returns improve.
PEG is 0.39x. Price is low relative to embedded growth, though the ratio depends heavily on forecast quality.
The cash conversion cycle is 62.2 days versus 57.8 days initially. Turnover changed little.
Valuation takeaway
TEGNA 's profile looks neutral, with price and fundamental efficiency broadly aligned.
Annual Financial Ratios TEGNA
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
15.3 | 5.0 | 6.1 | 6.2 | 10.6 | 8.1 | 12.9 | 6.2 | 12.1 | 7.2 | 7.5 | 3.8 | 9.8 | 6.3 | 4.6 | - | - | - | - | - |
P/S |
1.2 | 1.0 | 1.0 | 1.2 | 1.7 | 1.3 | 1.6 | 1.1 | 1.7 | 0.9 | 1.1 | 0.7 | 0.7 | 0.5 | 0.4 | - | - | - | - | - |
EPS |
1.4 | 3.5 | 2.3 | 2.8 | 2.1 | 2.2 | 1.3 | 1.9 | 1.3 | 2.0 | 2.0 | 4.7 | 1.7 | 1.8 | 1.9 | 2.5 | 1.5 | -29.1 | 4.5 | - |
EV (Enterprise Value) |
6.79 B | 6.63 B | 6.81 B | 7.61 B | 9.36 B | 8.64 B | 9.03 B | 6.32 B | 7.18 B | 9.12 B | 9.4 B | 11.9 B | 9.9 B | 6.55 B | 6.22 B | 4.22 B | 5.22 B | 6.45 B | -77.2 M | -94.3 M |
EBITDA per Share |
3.13 | 5.02 | 3.82 | 4.7 | 3.91 | 4.28 | 3.06 | 3.58 | 2.91 | 5.59 | 4.71 | 5.49 | 3.54 | 3.79 | 3.89 | 4.96 | 3.97 | - | - | - |
EV/EBITDA |
13.4 | 7.8 | 8.6 | 7.2 | 10.6 | 7.1 | 11.8 | 6.9 | 9.9 | 5.9 | 7.1 | 6.4 | 7.6 | 4.0 | 3.6 | 3.6 | 5.6 | -1.0 | -0.0 | - |
PEG |
-5.7 | 0.39 | 1.67 | 0.52 | -6.47 | 2.12 | -0.44 | -0.59 | 8.26 | 0.25 | -0.12 | 0.02 | -1.32 | -1.24 | -0.2 | - | - | - | - | - |
P/B |
1.1 | 1.0 | 1.1 | 1.3 | 2.0 | 1.9 | 2.3 | 1.9 | 3.3 | 1.4 | 1.6 | 1.3 | 1.4 | 1.1 | 0.9 | - | - | - | - | - |
P/CF |
10.3 | 4.4 | 4.9 | 4.8 | 10.0 | 4.8 | 17.7 | 5.5 | 10.7 | 5.3 | 7.0 | 5.8 | 9.5 | 4.0 | 2.8 | - | - | - | - | - |
ROE % |
6.97 | 19.96 | 17.62 | 20.52 | 18.93 | 23.46 | 18.00 | 30.25 | 27.51 | 19.23 | 20.96 | 32.63 | 14.43 | 18.05 | 19.70 | 27.18 | 22.15 | -629.57 | 11.71 | - |
ROA % |
3.20 | 8.19 | 6.81 | 8.60 | 6.89 | 7.05 | 4.12 | 7.69 | 5.52 | 5.11 | 5.38 | 9.45 | 4.21 | 6.65 | 6.93 | 8.63 | 4.97 | -85.26 | - | - |
ROCE % |
6.87 | 11.47 | 11.19 | 14.31 | 12.29 | 13.56 | 8.40 | 13.99 | 11.87 | 12.67 | 10.77 | 10.47 | 8.98 | 14.51 | 14.26 | 46.20 | 44.82 | -637.18 | 18.31 | - |
Current Ratio |
1.8 | 1.7 | 1.6 | 1.7 | 1.6 | 1.4 | 2.0 | 1.7 | 2.0 | 1.3 | 1.3 | 1.2 | 1.9 | 1.1 | 1.2 | 1.5 | 1.3 | 1.2 | - | - |
DSO |
81.3 | 72.3 | 80.4 | 72.4 | 72.8 | 70.4 | 95.5 | 73.8 | 84.3 | 67.9 | 68.8 | 36.0 | 61.0 | 47.7 | 49.5 | 49.6 | 53.2 | 23.3 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | 4.7 | 6.3 | 6.9 | 6.2 | - | - | - | - | - |
DPO |
19.0 | 21.0 | 20.3 | 16.1 | 15.0 | 13.3 | 15.4 | 28.5 | 20.7 | 42.5 | 34.7 | 13.7 | 22.3 | 23.3 | 23.8 | - | - | - | - | - |
Operating Cycle |
81.3 | 72.3 | 80.4 | 72.4 | 72.8 | 70.3 | 95.5 | 73.8 | 84.3 | 67.9 | 68.8 | 40.6 | 67.4 | 54.6 | 55.6 | 49.6 | 53.2 | 23.3 | - | - |
Cash Conversion Cycle |
62.2 | 51.3 | 60.1 | 56.3 | 57.8 | 57.0 | 80.0 | 45.3 | 63.5 | 25.4 | 34.1 | 27.0 | 45.1 | 31.3 | 31.8 | 49.6 | 53.2 | 23.3 | - | - |
All numbers in USD currency
Quarterly Financial Ratios TEGNA
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q4 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1499999999999999 | 0.89 | 0.48 | 1.06 | - | 0.89 | 0.48 | 1.06 | - | 0.48 | 0.92 | 0.46 | - | 0.65 | 0.59 | 0.6 | - | 0.58 | 0.48 | 0.51 | - | 0.6 | 0.09 | 0.4 | - | 0.22 | 0.37 | 0.34 | - | 0.45 | 0.43 | 0.26 | - | 0.2 | -0.6 | 0.27 | - | 0.55 | 0.46 | 0.39 | - | 0.39 | 0.51 | 0.5 | - | 0.52 | 0.92 | 0.26 | - | 0.35 | 0.5 | 0.46 | - | 0.58 | 0.51 | 0.29 | - | 0.42 | 0.63 | 0.38 | -29.97 | 0.31 | 0.3 | 0.34 | - | 0.69 | -10.03 |
EBITDA per Share |
6.44 | 1.47 | 0.92 | 0.85 | - | 1.49 | 0.93 | 0.93 | - | 746 | 1.36 K | 900 | - | 1.1 | 1.06 | 1.08 | - | 1.38 | 1.12 | 1.03 | - | 1.49 | 0.65 | 0.95 | - | 0.85 | 0.87 | 0.72 | - | 1.01 | 0.91 | 0.73 | - | 1.09 | 1.15 | 0.81 | - | 1.58 | 1.21 | 1.16 | - | 1.07 | 0.93 | 1.16 | - | 1.63 | 1.61 | 1.17 | - | 1.37 | 1.31 | 0.87 | - | 1.57 | 1.34 | 0.78 | - | 1.45 | 1.42 | 0.95 | - | - | - | - | - | - | - |
ROE % |
15.81 | 19.03 | 17.07 | 21.13 | 14.84 | 18.09 | 19.85 | 20.22 | 13.45 | 18.52 | 20.07 | 18.31 | 15.00 | 20.30 | 19.95 | 20.41 | 15.29 | 21.71 | 17.38 | 16.85 | 11.59 | 14.63 | 13.23 | 16.91 | 12.72 | 19.96 | 23.82 | 22.91 | 18.26 | 24.32 | -3.01 | -7.39 | -11.50 | -6.28 | -7.96 | 15.89 | 13.37 | 17.39 | 17.45 | 18.22 | 14.46 | 18.10 | 20.48 | 17.01 | 11.86 | 14.82 | 15.40 | 12.88 | 11.06 | 16.72 | 18.86 | 17.55 | 13.66 | 17.95 | 18.80 | 17.59 | 14.68 | -61.63 | -61.04 | -63.07 | -62.51 | 49.55 | 58.23 | -141.26 | 35.75 | 13.55 | -195.01 |
ROA % |
6.48 | 7.74 | 6.90 | 8.45 | 5.88 | 7.21 | 7.98 | 8.23 | 5.56 | 7.61 | 8.16 | 7.31 | 5.90 | 7.75 | 7.26 | 7.01 | 5.05 | 6.98 | 5.42 | 5.12 | 3.48 | 4.18 | 3.40 | 4.17 | 2.91 | 4.75 | 5.81 | 5.70 | 4.64 | 5.50 | 1.03 | 0.44 | -0.60 | 0.79 | 1.09 | 4.72 | 3.55 | 4.59 | 4.56 | 4.73 | 3.73 | 4.78 | 5.61 | 4.77 | 3.45 | 4.31 | 4.48 | 3.75 | 3.22 | 5.31 | 6.33 | 6.17 | 5.03 | 6.54 | 6.75 | 6.24 | 5.17 | -91.10 | -91.42 | -92.62 | -92.90 | 41.81 | 42.66 | 12.19 | 38.44 | 2.04 | -29.38 |
ROCE % |
10.72 | 10.87 | 9.65 | 9.64 | 7.63 | 9.60 | 10.34 | 10.69 | 8.62 | 12.08 | 13.46 | 12.54 | 10.06 | 13.28 | 12.67 | 12.34 | 9.11 | 12.66 | 10.61 | 10.48 | 7.45 | 9.07 | 7.68 | 8.52 | 5.80 | 8.94 | 10.46 | 11.09 | 9.08 | 11.76 | 12.12 | 11.05 | 8.26 | 10.71 | 10.12 | 9.30 | 7.23 | 10.09 | 10.09 | 10.38 | 7.70 | 9.58 | 9.18 | 8.82 | 6.42 | 8.56 | 9.22 | 8.63 | 6.56 | 10.70 | 17.77 | 21.01 | 19.12 | 27.64 | 33.88 | 32.34 | 26.57 | -53.20 | -52.81 | -55.06 | -53.23 | 64.69 | 77.84 | -111.91 | 38.14 | 22.06 | -181.63 |
Current Ratio |
1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | 1.8 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 | 1.2 |
DSO |
81.2 | 68.3 | 77.6 | 78.5 | - | 68.7 | 77.7 | 80.7 | - | 76.8 | 76.8 | 79.8 | - | 68.5 | 73.1 | 75.7 | - | 71.8 | 74.8 | 73.1 | - | 68.1 | 87.0 | 75.5 | - | 96.2 | 98.9 | 88.9 | - | 72.0 | 74.1 | 75.6 | - | 80.0 | 75.9 | 78.8 | - | 67.8 | 93.9 | 67.2 | - | 67.0 | 67.1 | 68.2 | - | 98.2 | 57.0 | 56.7 | - | 60.8 | 58.4 | 55.8 | - | 47.3 | 47.4 | 51.4 | - | 50.0 | 47.4 | 53.0 | 26.8 | 52.9 | 50.0 | 53.2 | 32.1 | 47.2 | - |
DPO |
19.1 | 18.2 | 18.4 | 21.4 | - | 17.8 | 16.8 | 16.6 | - | 17.1 | 17.7 | 17.6 | - | 18.1 | 18.8 | 17.7 | - | 9.6 | 9.2 | 11.7 | - | 14.0 | 14.9 | 13.6 | - | 15.4 | 16.6 | 21.9 | - | 28.0 | 28.7 | 24.0 | - | 20.5 | 21.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 81.3 | 79.7 | 80.8 | - | 68.7 | 77.7 | 77.4 | - | 76.8 | 76.8 | 79.8 | - | 68.5 | 73.1 | 75.7 | - | 71.8 | 74.8 | 73.1 | - | 68.1 | 87.0 | 75.5 | - | 96.2 | 98.9 | 88.9 | - | 72.0 | 74.1 | 75.6 | - | 80.0 | 75.9 | 78.8 | - | 67.8 | 93.9 | 67.2 | - | 67.0 | 67.1 | 68.2 | - | 98.2 | 57.0 | 56.7 | - | 60.8 | 58.4 | 55.8 | - | 47.3 | 47.4 | 51.4 | - | 50.0 | 47.4 | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | 63.1 | 60.9 | 62.0 | - | 50.8 | 60.9 | 59.8 | - | 59.7 | 59.1 | 62.3 | - | 50.4 | 54.3 | 58.0 | - | 62.2 | 65.6 | 61.4 | - | 54.1 | 72.1 | 61.9 | - | 80.8 | 82.3 | 67.0 | - | 44.0 | 45.3 | 51.6 | - | 59.4 | 54.8 | 78.8 | - | 67.8 | 93.9 | 67.2 | - | 67.0 | 67.1 | 68.2 | - | 98.2 | 57.0 | 56.7 | - | 60.8 | 58.4 | 55.8 | - | 47.3 | 47.4 | 51.4 | - | 50.0 | 47.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company TEGNA , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Mexico
